From Wikipedia, the free encyclopedia
- Lawrence, Stacy (July 28, 2015). "Mallinckrodt to sell contrast business to French imaging player Guerbet for $270M". FierceBiotech.
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|